Top 4 Small-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Idenix Pharmaceuticals (NASDAQ: IDIX) has a PEG ratio of 0.11. Idenix's trailing-twelve-month revenue is $33.54 million.

Exelixis (NASDAQ: EXEL) has a PEG ratio of 0.17. Exelixis had $351.97 million in total cash for the latest quarter.

InterMune (NASDAQ: ITMN) has a PEG ratio of 0.30. InterMune is expected to post revenue of $20.91 million for the December quarter.

Lexicon Pharmaceuticals (NASDAQ: LXRX) has a PEG ratio 0.62. Lexicon's trailing-twelve-month revenue is $1.16 million.